PEN
PEN
NYSE · Health Care

Penumbra Inc

$334.17
-1.39 (-0.41%)
As of Mar 24, 9:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.40B
Net Income
177.46M
Gross Margin
67.1%
Profit Margin
12.7%
Rev Growth
+18.3%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.1% 67.1% 62.3% 62.3%
Operating Margin 13.5% 12.1% 10.5% 11.3%
Profit Margin 12.7% 12.0% 6.5% 7.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.40B 1.18B 10.27B 10.50B
Gross Profit 941.25M 795.45M 6.40B 6.54B
Operating Income 188.98M 143.73M 1.08B 1.18B
Net Income 177.46M 134.98M 671.18M 794.53M
Gross Margin 67.1% 67.1% 62.3% 62.3%
Operating Margin 13.5% 12.1% 10.5% 11.3%
Profit Margin 12.7% 12.0% 6.5% 7.6%
Rev Growth +18.3% +18.3% +21.2% -0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 105.05M 105.05M 6.99B 7.31B
Total Equity 6.48B 6.48B 5.78B 6.06B
D/E Ratio 0.02 0.02 1.21 1.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 190.36M 152.83M 1.52B 1.81B
Free Cash Flow 854.42M 874.28M